¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Annals of Hepatology

Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more

Follow us

X Facebook

Alert

Newsletter

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2025

6.2

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2025

9.6

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2025

1.446

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2025

1.378

Time to first decision

The median number of days it takes for an article to go from submission to first editorial decision.

See more

Time to first decision

8 days

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Cover Vol. 24. Issue S1.

Vol. 24. Issue S1.

Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

(September 2021)

Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

Ann Hepatol. 2021;24 Supl 1: 100366

Full text access

Share

EDITORIAL BOARD

Ann Hepatol. 2021;24 Supl 1: 100533

Open access

Share

P-1 PREVALENCE AND EPIDEMOLOGY OF BACTERIAL INFECTIONS IN PATIENTS WITH ALCOHOLIC HEPATITIS: A RETROSPECTIVE STUDY OF PATIENTS ADMITTED AT THE SAN RAFAEL DE ALAHUELA HOSPITAL, COSTA RICA

Alejandra Ochoa, Pablo Coste, José Moreno

Ann Hepatol. 2021;24 Supl 1: 100367

Open access

Share

P-2 HEPATIC STEATOSIS AMONG PEOPLE LIVING WITH HIV IN SOUTHERN BRAZIL: PREVALENCE AND RISK FACTORS

Marina Ferri-Pezzini, Hugo Cheinquer, Alexandre de Araujo, Carlos T. Schmidt-Cerski, Eduardo Sprinz, Fernando Herz-Wolff, Julia Poeta

Ann Hepatol. 2021;24 Supl 1: 100368

Open access

Share

P-3 IMPACT OF THE SUSTAINED VIROLOGICAL RESPONSE ON THE GLUCOSE METABOLISM IN PATIENTS WITH HEPATITIS C

Fabia Benetti, Ítalo de Maman Júnior, Cristina Coelho Borges Cheinquer, Fernando Wolff, Alexandre de Araújo, Hugo Cheinquer

Ann Hepatol. 2021;24 Supl 1: 100369

Open access

Share

P-4 ALBUMIN LEVELS HAVE STRONGASSOCIATION WITH MORTALITY IN COVID-19 INFECTED PATIENS

Martín Uriel Vázquez-Medina, Cesar Montejo-Velázquez, Cruz Vargas-De-León, Arcelia Carolina Barrón-Campos, José Antonio Almeyda-Farfán, Julián Gonzalo Gándara-Calderón, Claudia Pantaleón-Martínez, Nerina del Carmen Fernández-Martínez, ... Eira Cerda-Reyes

Ann Hepatol. 2021;24 Supl 1: 100370

Open access

Share

P-5 HEPATITIS E VIRUS INFECTION INCREASES THE RISK OF DIABETES AND MORTALITY IN HCV infected patients

Patricia Momoyo Yoshimura Zitelli, Michele Gomes-Gouvêa, Daniel F. Mazo, Julio da Motta Singer, Claudia PMS Oliveira, Alberto Queiroz Farias, João Renato Pinho, Ryan YukimatsuTanigawa, ... Mário Guimarães Pessoa

Ann Hepatol. 2021;24 Supl 1: 100371

Open access

Share

P-6 SOFOSBUVIR CONTAINING REGIMENS ARE SAFE AND EFFECTIVE IN ADOLESCENTS WITH CHRONIC HEPATITIS C INFECTION

Stefan Wirth, Regino Gonzalez-Peralta, Philip Rosenthal, Winita Hardikar, Jessica Wen, Maureen M. Jonas, Naveen Mittal, Mary Whitworth, ... William Balistreri

Ann Hepatol. 2021;24 Supl 1: 100372

Open access

Share

P-7 CLINICAL AND HISTOPATHOLOGICAL FEATURES OF THIRTY-FIVE OBLITERATIVE PORTAL VENOPATHY PATIENTS AND POTENTIAL ROLE OF XENOBIOTICS

Vinicius Santos Nunes, Gildasio Junior, Maria Isabel SchinoiI, Luis Freiras, Raymundo Prana

Ann Hepatol. 2021;24 Supl 1: 100373

Open access

Share

P-8 PRESERVATION OF THROMBIN GENERATION IN CIRRHOSIS DESPITE ABNORMAL RESULTS OF INTERNATIONAL NORMALIZED RATIO: IMPLICATIONS FOR INVASIVE PROCEDURES

Caroline Marcondes Ferreira, Tania Rubia Flores da Rocha, Evandro Oliveira Souza, Flair Jose Carrilho, Elbio Antonio D'amico, Alberto Queiroz Farias

Ann Hepatol. 2021;24 Supl 1: 100374

Open access

Share

P-9 SAFETY AND EFFECTIVENESS OF DIRECT ACTING AGENTS FOR HCV TREATMENT AFTER LIVER TRANSPLANTATION IN RIO DE JANEIRO (BRAZIL)

L.C.M. Pinto, E. Balbi, Halpern, L.P. Carius, J. Roma, L.F.P. Moreira, H. Perazzo

Ann Hepatol. 2021;24 Supl 1: 100375

Open access

Share

P-10 LATIN AMERICAN REGISTRY OF CHOLANGIOCARCINOMA: CLINICAL FEATURES, MANAGEMENT AND OUTCOMES

Leonardo G. da Fonseca, Laura Izquierdo-Sanchez, Pedro H. Hashizume, Estefanía Liza Beca, Yanina Carlino, Enrique Carrera, Marco Arrese, Javier Díaz Ferrer, ... Jesus M. Banales

Ann Hepatol. 2021;24 Supl 1: 100376

Open access

Share

P-11 POTENTIALLY HEPATOTOXIC DRUGS ARE STILL BEING PRESCRIBED TO LIVER DISEASE PATIENTS UNDER TERTIARY CARE: IT IS TIME TO SAY ENOUGH

Rodrigo Dorelo, Samantha T.A. Barcelos, Magela Barros, Valeria Elustondo, Ysela Y.P. Pérez, Martin Oricchio, Nelson D.S. Uribe, Nelia Hernandez, ... Mário R. Álvares-da-Silva

Ann Hepatol. 2021;24 Supl 1: 100377

Open access

Share

P-12 QUALITATIVE EVALUATION OF NATURAL PRODUCTS USED BY PATIENTS IN A BRAZILIAN HEPATOTOXICITY AMBULATORY

Caio Medina Lopes, Andréia de Santana Souza, Ademir do Vale, Juceni Pereira David, Genario Santos, Vinicius Santos Nunes, Maria Isabel Schinoni, Raymundo Paraná

Ann Hepatol. 2021;24 Supl 1: 100378

Open access

Share

P-13 COMPARISON OFF DIFFERENT PROGNOSTIC SCORES FOR PATIENTS WITH CIRRHOSIS HOSPITALIZED WITH SARS – COV 2 INFECTION

Manuel Mendizabal, Ezequiel Ridruejo, Federico Piñero, Margarita Anders, Martín Padilla, Luis G. Toro, Aldo Torre, Pedro Montes, ... Marcelo O. Silva

Ann Hepatol. 2021;24 Supl 1: 100379

Open access

Share

P-14 EVALUATION AND SELECTION OF CANDIDATES FOR LIVER TRANSPLANTATION: AN ECONOMIC PERSPECTIVE. RETROSPECTIVE STUDY

Santiago Rodríguez, Fabio Da Motta, Giacomo Balbinoto Neto, Ajacio Brandão

Ann Hepatol. 2021;24 Supl 1: 100380

Open access

Share

P-15 WAITING LIST FOR LIVER TRANSPLANTATIOS: CLINICAL AND ECONOMIC BURDEN, RETROSPECTIVE STUDY

Santiago Rodríguez, Fabio Da Motta, Giacomo Balbinoto Neto, Ajacio Brandão

Ann Hepatol. 2021;24 Supl 1: 100381

Open access

Share

P-18 PREVALENCE AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFECTIONS IN PATIENTS WITH CHRONIC LIVER DISEASE: RETROSPECTIVE ANALYSIS FROM A GENERAL HOSPITAL IN MONTERREY, NUEVO LEON, MEXICO

José Alfredo Salinas-Casanova, Daniel Almaguer-Morales, Salvador Bruno Valdovinos-Chávez, Luis Alonso Morales-Garza, María Teresa Sánchez-Ávila, Juan Francisco Sánchez-Ávila

Ann Hepatol. 2021;24 Supl 1: 100382

Open access

Share

P-19 ANTI-RIBOSOMAL P (ANTI-P) ANTIBODIES IN AUTOIMMUNE HEPATITIS PATIENTS

Clarisse de Almeida Gallo, Alessandra Delavance, Antônio Eduardo Silva, Luis Eduardo Andrad, Ivonete Silva, Maria Lúcia Ferraz

Ann Hepatol. 2021;24 Supl 1: 100383

Open access

Share

P-20 METABOLIC ASSOCIATED FATTY LIVER DISEASE: FIBROSIS AND SARCOPENIA FREQUENCIES

Priscila Pollo Flores, Débora Vieira Soares, Maria Auxiliadora Saad, Clara Petrucio, Wallison Rodrigues Gonçalves, Caio Oliveira Menezes, Gabriella Mundim, Gabriella Santos, ... Gabriela Muller Machado

Ann Hepatol. 2021;24 Supl 1: 100384

Open access

Share

P-21 BONE MASS, VITAMIN D LEVELS AND NONALCOHOLIC FATTY FIVER DISEASE

Clara Petrucio, Wallison Rodrigues Gonçalves, Caio Oliveira Menezes, Gabriel Alverca Meyas, Vanessa da Costa Rodrigues, Flavio Marques de Oliveira Filho, Maria Auxiliadora Saad, Priscila Pollo Flores, Débora Vieira Soares

Ann Hepatol. 2021;24 Supl 1: 100385

Open access

Share

P-22 ANALYSIS OF FEATURES ASSOCIATED WITH DIFFICULTY IN SCREENING AND EARLY DIAGNOSING HEPATOCELLULAR CARCINOMA IN RISK PATIENTS

João Eugênio Loureiro Lopes, Júlia Antunes RizzoBicalho, Livia Zardo Trindade, Mariana Poltronieri Pacheco

Ann Hepatol. 2021;24 Supl 1: 100386

Open access

Share

P-23 SEROLOGICAL PROFILE OF HEPATITIS B AND C IN REUMATHOLOGIC PATIENTS IN USE OF IMMUNOSSUPRESSIVE THERAPY

Gabriela Azevedo Solino, Camilla Bortolini Chamoun, Victoria Caroline Danielle Da Silva, Valquíria Garcia Dinis, Mariana Poltronieri Pacheco

Ann Hepatol. 2021;24 Supl 1: 100387

Open access

Share

P-24 FREQUENCY AND SEVERITY OF LIVER INVOLVEMENT IN PREGNANT WOMEN ADMITTED TO AN INTENSIVE CARE UNIT WITH HYPERTENSIVE DISORDERS OF PREGNANCY

J. Castro, M. De Lucca, L. Codes, M.A. Soares, L. Lyrio, P. Bittencourt

Ann Hepatol. 2021;24 Supl 1: 100388

Open access

Share

P-25 SLOWER FIBROSIS PROGRESSION IN HEPATITIS C HEMOPHILIAC PATIENTS?

Dauana O. Bastos, Christini Emori, Sandra V. Antunes, Flavia Appel, Maria Lucia Ferraz

Ann Hepatol. 2021;24 Supl 1: 100389

Open access

Share

P-26 PORTAL VENOUS THROMBOSIS IN TRANSPLANTED CIRRHOTIC PATIENTS AT THE “HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE”

V.N. Henríquez Auba, F. Ramirez, M. Fabres, P. Abarca, B. Astrosa, D. Vera, J.C. Diaz, J. Castillo, ... A. Urzua

Ann Hepatol. 2021;24 Supl 1: 100390

Open access

Share

P-27 ALTERATION IN LIVER FUNCTION TESTS AMONG PATIENTS HOSPITALIZED FOR COVID-19: A MULTICENTRIC STUDY IN PERU

Ivania Marín Dueñas, Jenny Vega, Hugo Carrillo-Ng, Isabel Veramendi-Schult, Ricardo Zavaleta Alva, Luis Vásquez, Zeneida Gonzales-Soler, Hellen Agurto-Lescano, ... Adelina Lozano

Ann Hepatol. 2021;24 Supl 1: 100391

Open access

Share

P-28 BODY COMPOSITION MEASUREMENT AND NONALCOHOLIC FATTY LIVER DISEASE

Maria Auxiliadora Nogueira Saad, Débora Vieira Soares, Priscila Pollo Flores, Rosa Leonora Salerno Soares, Vinicius César Jardim Pereira, Maria Clara Brito Pontes

Ann Hepatol. 2021;24 Supl 1: 100392

Open access

Share

P-29 CLINICAL FEATURES OF PRIMARY BILIARY CHOLANGITIS IN BRAZIL

Guilherme G.L. Cançado, Eduardo L.R. Cançado, Maria L.G. Ferraz, Cristiane A. Villela-Nogueira, Debora R.B. Terrabuio, Michelle H. Braga, Mateus J. Nardelli, Luciana C. Faria, ... members of the Brazilian Cholestasis Study Group Consortium

Ann Hepatol. 2021;24 Supl 1: 100393

Open access

Share

P-30 IMPACT OF PUBLIC HEALTH POLICIES ON ALCOHOL-ASSOCIATED LIVER DISEASE IN LATIN AMERICA: AN ECOLOGICAL MULTI-NATIONAL STUDY

Antonio Díaz Luis, Francisco Idalsoaga, Eduardo Fuentes-López, Andrea Márquez, Carolina A. Ramírez, Juan Pablo Roblero, Araujo Roberta C., Fátima Higuera – de – la – tijera, ... Juan Pablo Arab

Ann Hepatol. 2021;24 Supl 1: 100394

Open access

Share

P-31 NORMAL TRANSAMINASES IN OBESE PATIENTS WITH METABOLIC ASSOCIATED STEATOHEPATITIS

Adelina Lozano, Hugo Carrillo-Ng, Cesar Castro, Zenaida Lozano, Lil Saavedra, Gustavo Salinas

Ann Hepatol. 2021;24 Supl 1: 100395

Open access

Share

P-32 EVALUATION OF HEPATIC FIBROSIS THROUGH NON-INVASIVE METHODS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND C

Felipe José de Oliveira Fraga, Leila Maria Soares Tojal de Barros Lima

Ann Hepatol. 2021;24 Supl 1: 100396

Open access

Share

P-33 EVALUATION OF CIRCULATING METABOLOME IN THE SEARCH OF POTENTIAL DRUG-INDUCED LIVER INJURY BIOMARKERS

Daniel E. Di Zeo-Sánchez, Inmaculada Medina-Cáliz, Judith Sanabria-Cabrera, Miren Garcia-Cortes, Aida Ortega-Alonso, Alejandro Cueto-Sanchez, Rocio San Juan-Jimenez, Andrés Gonzalez-Jimenez, ... Mercedes Robles-Diaz

Ann Hepatol. 2021;24 Supl 1: 100397

Open access

Share

P-34 OUTCOME OF HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRALS AFTER UNIVERSAL ACCESS TO THERAPY

S. Blanco-Sampascual, I. Gorostiza-Hormaetxe, F. Menéndez-Blázquez, P. Ruiz-Eguiluz, A. Baranda-Martín, A. Castrillo-Olabarria, M.A. Gómez-Suárez, A. Calderón-García

Ann Hepatol. 2021;24 Supl 1: 100398

Open access

Share

P-35 NONINVASIVE PREDICTORS OF ESOPHAGEAL VARICES IN PATIENTS WITH HEPATOSPLENIC SCHISTOSOMIASIS MANSONI: MULTICENTER STUDY

Mateus Jorge Nardelli, Zulane da Silva Tavares Veiga, Luciana Costa Faria, Gustavo Henrique Santos Pereira, Catherine Ferreira da Silva, Fernanda Aziz Barbosa, Flávia Ferreira Fernandes, Renata de Mello Perez, ... Claudia Alves Couto

Ann Hepatol. 2021;24 Supl 1: 100399

Open access

Share

P-36 ACCURACY OF PROGNOSTIC SCORES IN PREDICTION OF MORTALITY IN CIRRHOTIC PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT

Pedro Silva, Fernanda Rios, Liana Codes, Carolina Esteve, Murilo Filho, Douglas Lima, Geraldo Filho, Bruno Lima, ... Paulo Bittencourt

Ann Hepatol. 2021;24 Supl 1: 100400

Open access

Share

P-37 EXPERIENCE IN MEXICO WITH DIRECT ACTING ANTIVIRALS AS A TREATMENT FOR HEPATITIS C

J.L. Pérez Hernández, Aldo Torre Delgadillo, Graciela Castro Narro, Eira Cerda Reyes, Mayra Virginia Ramos Gómez, Leonardo Juárez Chávezx, Margarita Dehesa Violante, Linda Muñoz Espinosa, ... María de Fátima Higuera de la Tijera

Ann Hepatol. 2021;24 Supl 1: 100401

Open access

Share

P-38 UTILITY OF PUPILLARY REACTIVITY IN THE FUNCTIONAL ASSESSMENT OF THE AUTONOMOUS NERVOUS SYSTEM IN PATIENTS WITH CHRONIC LIVER DISEASE: PRELIMINARY RESULTS

Christian Lara, Abraham Gajardo, Flavia Giubergia, Nicolás Bustos, Juan Pablo Roblero, Alvaro Urzúa, Jaime Poniachik, Máximo Cattaneo

Ann Hepatol. 2021;24 Supl 1: 100402

Open access

Share

P-39 EXPERIENCE IN THE MANAGEMENT OF REFRACTORY HEPATIC ENCEPHALOPATHY THROUGH ENDOVASCULAR THERAPY

Claudia Muñoz, Felipe Ramírez, Nicolás Martínez, Patricio Palavecino, Claudia Pavez, Alvaro Urzúa, Máximo Cattaneo, Juan Pablo Roblero, Jaime Poníachik

Ann Hepatol. 2021;24 Supl 1: 100403

Open access

Share

P-40 SEVERE AUTOIMMUNE HEPATITIS: CORTICOSTEROID THERAPY OR EARLY ENROLLMENT TO LIVER TRANSPLANTATION

Andrea Jiménez, Alan Poniachik, Eladio González, Andrés De la Vega, Máximo Cattaneo, Juan Pablo Roblero, Jaime Poniachik, Alvaro Urzúa

Ann Hepatol. 2021;24 Supl 1: 100404

Open access

Share

P-41 TRENDS IN HOSPITALIZATION, CHARACTERISTICS AND MORTALITY OF HOSPITALIZED PATIENTS WITH CIRRHOSIS IN CHILE

Juan Pablo Roblero, Juan Pablo Arab, Christian Von Muhlenbrock, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1: 100405

Open access

Share

P-42 SEROPREVALENCE OF IgG and IgM ANTI-HEV ANTIBODIES USING AN AUTOMATED METHOD: EXPERIENCE OF A UNIVERSITY CENTER

Natalia Covarrubias, Constanza Bohle, Christian Lara, Julio Miranda, Carmen Hurtado, Mauricio Venegas

Ann Hepatol. 2021;24 Supl 1: 100406

Open access

Share

P-43 INDICATORS OF RESPONSE TO FIRST TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELULLAR CARCINOMA

Alejandra Domínguez, Gabriel Puelma, Marcelo Salinas, Máximo Cattaneo, Javier Ortiz, Patricio Palavecino, Alvaro Urzúa, Juan Pablo Roblero, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1: 100407

Open access

Share

P-44 TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH CONTROVERSIAL INDICATION

Alejandra Domínguez, Gabriel Puelma, Marcelo Salinas, Máximo Cattaneo, Alvaro Urzúa, Juan Pablo Roblero, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1: 100408

Open access

Share

P-45 LIVER HEMODYNAMIC AND TRANSJUGULAR LIVER BIOPSY: ROLE IN DIAGNOSTIC AND THERAPEUTIC BEHAVIOR

Alvaro Urzúa, Jaime Poniachik

Ann Hepatol. 2021;24 Supl 1: 100409

Open access

Share

P-46 EPIDEMIOLOGICAL PROFILE AND CLINICAL OUTCOMES OF PATIENTS INTOXICATED WITH ACETAMINOPHEN FOR SUICIDAL PURPOSES AT HOSPITAL SAN VICENTE FUNDACIÓN RIONEGRO: A CASE SERIES

Daniel Vasquez, Luis Guillermo Toro, Marle Duque, Lina María Ramiréz, Luisa Fernanda Ahunca, Diana Restrepo

Ann Hepatol. 2021;24 Supl 1: 100410

Open access

Share

P-47 HISTOPATHOLOGICAL ANALYSIS OF 10-YEAR PROTOCOL LIVER ALLOGRAFT BIOPSY OF ASYMPTOMATIC PEDIATRIC RECIPIENTS FROM A SINGLE BRAZILIAN CENTER

Luciana E. Soares, Carlos Thadeu Carski, Carlos O. Kieling, Marina Adami, Renata Rostirola Guedes, Ariane Backes, Ian Leipnitz, Sandra M.G. Vieira

Ann Hepatol. 2021;24 Supl 1: 100411

Open access

Share

P-48 HEPATITIS DELTA: THE MOST SEVERE OF ALL VIRAL HEPATITIS

Júlia Teixeira Ton, Ester Teixeira Ton, Alcione de Oliveira dos Santos, Juan Miguel Villalobos Salcedo, Deusilene Vieira Dallácqua, Mariana Pinheiro Alves Vasconcelos

Ann Hepatol. 2021;24 Supl 1: 100412

Open access

Share

P-49 COVID 19-PANDEMIC AND OUTCOMES IN DECOMPENSATE CIRRHOSIS-10 MONTHS REVIEW

Priscila Pollo-Flores, Gabriel Alverca Meyas, Vanessa Rodrigues, Janaisa Moraes de Souza, Pamela Moura Rodrigues Cardoso, Iasmin Torres Leitão, Stephanie Cathren Fenizola dos Santos da Silva, Lívia Melo Villar

Ann Hepatol. 2021;24 Supl 1: 100413

Open access

Share

P-50 PREVALENCE OF HEPATITIS AMONG STUDENTS AND HEALTH PROFESSIONALS AT THE FEDERAL UNIVERSITY OF BAHIA

Jacy Andrade, Lucas Sousa Macêdo, Fernanda Bastos, Marco Antônio Vasconcelos Rêgo, Robert Eduard Schaer, Roberto Meyer, Juçara Magalhães Simões, Songeli Menezes Freire, ... Maria Isabel Schinoni

Ann Hepatol. 2021;24 Supl 1: 100414

Open access

Share

Publish in

Annals of Hepatology

Affiliated societies

asdasdasd